1. ABP reduces operating costs by approximately 60% through optimization. 2. 1-for-30 reverse stock split effective to comply with Nasdaq listing. 3. Celltrion funds key ABP-102 development, retaining commercial rights for Abpro. 4. DiversImmune and MultiMab platforms aim to enhance pipeline value. 5. ABP positioned for growth with lean cost structure and strategic partnerships.

1. SDL has signed an agreement to acquire Dream Dentistry Labs. 2. Acquisition expands SDL's presence in Central Florida's dental market. 3. Dream Dentistry is expected to exceed $1 million in revenue for 2025. 4. SDL is negotiating with four other dental labs for potential acquisitions. 5. Acquisition includes performance-based shares contingent on operational milestones.

1. Charles Schwab to acquire Forge Global for $660 million. 2. Forge operates a premier private market trading platform. 3. Acquisition expected to enhance liquidity and investor access. 4. Schwab's existing client base will significantly benefit from this deal. 5. Expected transaction close in the first half of 2026.

1. TGE announces a $5 million share repurchase program until January 31, 2026. 2. The board believes Class A shares are currently undervalued at $17.3. 3. Significant short interest is observed surrounding TGE's Class A ordinary shares. 4. Share buyback aims for long-term growth and stabilizing share price. 5. TGE's diversified business includes media, entertainment, and hospitality services.

1. Denny's will be acquired for $6.25 per share in cash. 2. The purchase price is a 52.1% premium over the previous closing price. 3. Transaction anticipated to close in Q1 2026, pending approvals. 4. Denny's will become privately held post-acquisition. 5. TriArtisan, Treville, and Yadav Enterprises are primary investors in the deal.